Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
- (-) Complementary medicines (8)
- (-) Assessed listed medicines (1)
- Advertising (135)
- Regulatory compliance (74)
- COVID-19 (55)
- Prescription medicines (43)
- Therapeutic goods regulation (38)
- COVID-19 vaccines (26)
- Vaping hub (25)
- Compliance and enforcement hub (17)
- Import and export (12)
- Medicinal cannabis hub (11)
- Labelling and packaging (8)
- Scheduling (national classification system) (8)
- Legislation (7)
- Medicine safety (7)
- Australian Register of Therapeutic Goods (ARTG) (6)
- Over the counter (OTC) medicines (6)
- Weight loss products (6)
- Safety (5)
- Alert/Advisory (4)
- Manufacturing (4)
- Non-prescription medicines (4)
- Shortages (4)
- Cosmetics (2)
- Listed medicines (2)
- Medical devices safety (2)
- In Vitro Diagnostic medical devices (IVDs) (1)
Search
9 result(s) found, displaying 1 to 9
-
NoticesListed medicine ingredients and requirements for their use have been updated in the Therapeutic Goods (Permissible Ingredients) Determination (No. 1) 2025, which commenced on 1 March 2025
-
Media releasesThe TGA has issued 2 infringement notices totalling $37,560 to Queensland-based company Akula Foods Pty Ltd for the alleged unlawful import of unregistered complementary medicines
-
Media releasesThe TGA has issued 4 infringement notices totalling $75,120 to Liquefy Health Pty Ltd for the alleged unlawful importation and advertising of unapproved complementary medicines.
-
News‘Haytox’ has not been approved by the TGA or included in the Australian Register of Therapeutic Goods (ARTG).
-
NewsFrom 30 November 2023, some sports supplements will be regulated as therapeutic goods and must be included in the Australian Register of Therapeutic Goods (ARTG).
-
NewsBefore you take a weight loss supplement or medicine, there are things to consider.
-
Media releasesThe TGA has issued one infringement notice to Queensland-based IMUNI Pty Ltd for allegedly advertising a complementary medicine for a therapeutic use that was not permitted.
-
Media releasesThe TGA has issued two infringement notices totalling $5,328 to a Queensland-based individual for the alleged unlawful use of a prohibited representation and endorsement in advertising a listed complementary medicine.
-
Media releasesToday the TGA announced a final decision to down-schedule certain low dose cannabidiol (CBD) preparations